ZHAOKE OPHTH-B News

ZHAOKE OPHTH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024

Jan 3 16:32

ZHAOKE OPHTH-B: VOLUNTARY ANNOUNCEMENT -NMPA ACCEPTANCE OF ABBREVIATED NEW DRUGAPPLICATION FOR NVK002 FOR TREATMENT OFMYOPIA PROGRESSION IN CHILDREN

Jan 2 18:40

ZHAOKE OPHTH-B: VOLUNTARY ANNOUNCEMENT - POSITIVE TOP-LINE RESULTS FROM TAB014 PHASE III CLINICAL TRIAL FOR THE TREATMENT OF wAMD

Jan 2 08:01

ZHAOKE OPHTH-B: INSIDE INFORMATION - MARKETING AUTHORIZATIONS OBTAINED FROM THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION FOR LATANOPROST EYE DROP, TRAVOPROST EYE DROP, AND TRAVOPROST TIMOLOL EYE DROP

Dec 9, 2024 17:22

ZHAOKE OPHTH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024

Dec 3, 2024 12:05

ZHAOKE OPHTH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024

Nov 4, 2024 11:42

ZHAOKE OPHTH-B: VOLUNTARY ANNOUNCEMENT - POSITIVE TOP-LINE RESULTS FROM NVK002 TWO-YEAR PHASE III CLINICAL TRIAL (CHINA CHAMP) IN CHINA FOR THE TREATMENT OF MYOPIA PROGRESSION IN CHILDREN

Oct 23, 2024 17:45

ZHAOKE OPHTH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024

Oct 2, 2024 10:45

ZHAOKE OPHTH-B: VOLUNTARY ANNOUNCEMENT - COMPLETION OF TAB014 PHASE III CLINICAL TRIAL LAST PATIENT LAST VISIT IN CHINA

Sep 26, 2024 16:30

ZHAOKE OPHTH-B: NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS AND REPLY FORM

Sep 23, 2024 16:45

ZHAOKE OPHTH-B: NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND REPLY FORM

Sep 23, 2024 16:41

ZHAOKE OPHTH-B: INSIDE INFORMATION - MARKETING AUTHORIZATION FORBIMATOPROST EYE DROP OBTAINED FROM THENATIONAL MEDICAL PRODUCTS ADMINISTRATION

Sep 20, 2024 06:10

ZHAOKE OPHTH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024

Sep 3, 2024 10:37

ZHAOKE OPHTH-B: VOLUNTARY ANNOUNCEMENT - APPROVAL OF INVESTIGATIONAL NEW DRUG APPLICATION FOR PHASE III CLINICAL TRIAL OF CYCLOSPORINE A (CsA) OPHTHALMIC GEL BY NMPA AND COMPLETION OF NVK002 PHASE III CHINA-CHAMP LAST PATIENT LAST VISIT IN CHINA

Aug 12, 2024 07:54

ZHAOKE OPHTH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024

Aug 1, 2024 11:10

ZHAOKE OPHTH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024

Jul 2, 2024 14:51

ZHAOKE OPHTH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024

Jun 3, 2024 17:51

ZHAOKE OPHTH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024

May 2, 2024 19:51

ZHAOKE OPHTH-B: NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND REPLY FORM

Apr 26, 2024 22:46

ZHAOKE OPHTH-B: NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS AND REPLY FORM

Apr 26, 2024 22:43